At Stanford University, research involving rDNA/sNA and/or Biohazardous Agents is regulated by the NIH and comes under review of the Stanford University Administrative Panel on Biosafety (APB). Research that involves the use of non-exempt materials as defined by the NIH (see Chapter 2) and clinical research that requires Institutional Biosafety Committee approval MUST be reviewed and approved by the APB prior to work being done. The APB uses the eProtocol system for submission and tracking of protocol.
The flow chart below illustrates the eProtocol Biosafety workflow.
Renewals and Amendments
Duration of approval for BSL- 2 projects is for three years, with a requirement for annual updates; BSL-3 and Clinical projects are approved for one year. Annual updates and revisions of projects are done through eProtocol Biosafety
For information about eProtocol Biosafety see their website.
